Methods of treating osteoarthritis using IL-17 receptor proteins in combination with TNF-receptor proteins
US7338930B2 · kind B2 · utility
1Cited by
3References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 20, 2005 |
| Grant date | Mar 4, 2008 |
| Priority date | — |
| Expiry date | Mar 16, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for regulating levels of nitric oxide are disclosed. The methods utilize IL-17 receptors, which may be used in conjunction with inhibitor of IL-1 and/or TNF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.